Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Supplement 1 , Pages S5-S13, December 2006

Update on the MA.17 extended adjuvant trial

  • Paul Goss (Director, Breast Cancer Research, Massachusetts General Hospital Cancer Center; Co-Director, Breast Cancer Disease Program, DF/HCC)

      Affiliations

    • Corresponding Author InformationTel.: +1 617 724 3118; Fax: +1 617 724 3166.

Massachusetts General Hospital Cancer Center, Gillette Center for Breast Cancer, Cox Building, Suite 640, 55 Fruit Street, YAW 9A, Boston, MA 02114, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-690X(06)00081-9

doi:10.1016/j.beem.2006.10.002

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Supplement 1 , Pages S5-S13, December 2006

Article Tools

* Image Usage & Resolution